- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Treats Adults
Mehdi S Mirsaeidi, MD, MPH
Pulmonologist, Critical Care Medicine Physician
Mehdi S Mirsaeidi, MD, MPH
- Additional languages:
- Persian
Request appointment online
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 30 Years - NA Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All
My publications
Filter publications
241 publications
2021
Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study.
Frontiers in pharmacology
鈥�2021
Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review.
Frontiers in medicine
鈥�2021
Machine-learning-based COVID-19 mortality prediction model and identification of patients at low and high risk of dying
Critical Care
2021
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Science immunology
鈥�2021
COVID-19 and cause of pregnancy loss during the pandemic: A systematic review.
PloS one
鈥�